IRIS UniCatt

Mazzone, Elena Stacy
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.211
NA - Nord America 1.536
AS - Asia 1.301
SA - Sud America 236
AF - Africa 37
OC - Oceania 1
Totale 5.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.474
DE - Germania 1.083
SG - Singapore 600
NL - Olanda 368
CN - Cina 298
IT - Italia 290
BR - Brasile 190
VN - Vietnam 96
FR - Francia 92
SE - Svezia 90
GB - Regno Unito 62
IE - Irlanda 53
JP - Giappone 46
IN - India 45
HK - Hong Kong 41
ID - Indonesia 40
CA - Canada 34
FI - Finlandia 33
RU - Federazione Russa 33
PL - Polonia 28
KR - Corea 24
BD - Bangladesh 22
TR - Turchia 22
AR - Argentina 16
ES - Italia 16
PK - Pakistan 13
MX - Messico 11
ZA - Sudafrica 11
IQ - Iraq 9
PE - Perù 9
EC - Ecuador 8
AT - Austria 7
CO - Colombia 7
UA - Ucraina 7
IL - Israele 6
LT - Lituania 6
PH - Filippine 6
SA - Arabia Saudita 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
DZ - Algeria 5
EG - Egitto 5
UZ - Uzbekistan 5
CH - Svizzera 4
IR - Iran 4
PA - Panama 4
TN - Tunisia 4
GT - Guatemala 3
JM - Giamaica 3
LV - Lettonia 3
MA - Marocco 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
KZ - Kazakistan 2
NG - Nigeria 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HT - Haiti 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.322
Salva come PNG Salva come JPEG
Città #
Singapore 354
Amsterdam 350
Frankfurt am Main 341
Ashburn 224
San Jose 190
Chandler 108
New York 94
Hefei 77
Los Angeles 53
Beijing 50
Rome 50
Tukwila 49
Dallas 47
Dublin 45
Tokyo 45
Lauterbourg 39
Hong Kong 38
Jakarta 38
Munich 38
Ho Chi Minh City 37
Milan 32
Chicago 31
Hanoi 27
Santa Clara 24
Seoul 24
São Paulo 21
Kent 20
Warsaw 20
Council Bluffs 17
Helsinki 17
Atlanta 16
Boston 16
Moscow 15
Palermo 15
Denver 14
Nuremberg 14
Boardman 13
Chennai 13
Houston 13
London 13
Turku 13
Poplar 11
Stockholm 11
Toronto 11
Düsseldorf 10
Marseille 10
Pune 10
Brooklyn 9
Buffalo 9
Lima 9
Orem 9
Johannesburg 8
Phoenix 8
Princeton 8
San Francisco 8
Ankara 7
Florence 7
Manchester 7
Montreal 7
San Mateo 7
Secaucus 7
Columbus 6
Falkenstein 6
Hangzhou 6
Istanbul 6
Wilmington 6
Brasília 5
City of London 5
Curitiba 5
Mexico City 5
Naples 5
Shenzhen 5
Tashkent 5
The Dalles 5
Turin 5
Ancona 4
Edinburgh 4
Fairfield 4
Haiphong 4
Kiel 4
Mumbai 4
New Delhi 4
Quito 4
Rio de Janeiro 4
Shanghai 4
Sofia 4
Washington 4
Bern 3
Bremen 3
Brno 3
Bucaramanga 3
Busto Arsizio 3
Calgary 3
Duque de Caxias 3
Faisalabad 3
Guatemala City 3
Harrisburg 3
Hyderabad 3
Karachi 3
Kyiv 3
Totale 2.990
Salva come PNG Salva come JPEG
Nome #
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 957
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 681
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 272
Performance of Upper Limb module for Duchenne muscular dystrophy 237
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 156
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 156
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 148
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 142
Our Experience on Temporal Bone Fractures: Retrospective Analysis of 141 Cases 138
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report 130
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 130
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 128
Sleep disorders in spinal muscular atrophy 116
Revised upper limb module for spinal muscular atrophy: Development of a new module 114
Clinical Variability in Spinal Muscular Atrophy Type III. 114
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 106
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 104
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 102
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 101
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA) 99
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 99
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 89
Old measures and new scores in spinal muscular atrophy patients 89
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 86
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 80
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 77
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 77
First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy 72
Early neurodevelopmental assessment in Duchenne muscular dystrophy 70
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients 67
Assessing upper limb function in nonambulant SMA patients: Development of a new module 62
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool 57
Daily salbutamol in young patients with SMA type II 54
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability 54
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy 53
Correction: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-Month changes 51
Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM 49
Reliability of the North Star Ambulatory Assessment in a multicentric setting 42
Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale 5
Totale 5.364
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 11 0 0 19 4 6 3 10 4 6 18 12
2022/2023359 19 30 26 44 30 59 17 34 51 12 20 17
2023/2024467 22 83 12 23 15 87 40 43 11 21 50 60
2024/2025852 22 15 82 25 60 53 47 34 82 69 209 154
2025/20263.591 267 68 177 321 470 1.419 339 98 130 118 122 62
Totale 5.364